At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
SmokefreeSGM +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SmokefreeSGM, A Text-based Smoking Cessation Feasibility Trial for Sexual and Gender Minority Groups
The University of Texas Health Science Center, Houston·interventional·Posted Dec 9, 2022·Updated Aug 17, 2025
In Brief
A clinical study evaluating SmokefreeSGM and SmokefreeTXT for Smoking Cessation. Completed, enrolled 100 participants across 1 site.
Detailed Summary
The purpose of this study is to test the feasibility and acceptability of Smokefree Sexual and Gender Minority (SGM), an SGM-tailored version of the SmokefreeTXT text messaging program
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartNov 2022
First PostedDec 2022
Primary CompletionJul 2024
TodayJul 2026
First PostedDec 9, 2022
Enrollment StartNov 10, 2022
Primary CompletionJul 9, 2024
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 3.6 years ago
Interventions
SmokefreeSGMbehavioral
Participants will be enrolled in a text-based smoking cessation program specifically designed to respond to the needs of LGBTQ+ smokers.
SmokefreeTXTbehavioral
Participants will be enrolled in a text-based smoking cessation program specifically designed to respond to the needs of the general population